Trial Profile
Phase II Study to evaluate efficacy and safety of Lenalidomide maintenance therapy for multiple myeloma patients under bortezomib treatment
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2014
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms L-Defense
- 02 Jul 2014 New trial record